Multiple Stargardt Contenders Progress In Japan Despite Small Market

Medical Need, Supportive Regulations

Japan has two P3 candidates for Stargardt's Disease.
Japan has two candidates for Stargardt in Phase III, despite small local market • Source: Shutterstock

More from Japan

More from Focus On Asia